Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
|
US |
|
Drilling Tools International Corp
NASDAQ:DTI
|
US |
|
Backblaze Inc
NASDAQ:BLZE
|
US |
|
Jerash Holdings (US) Inc
NASDAQ:JRSH
|
US |
|
Nacon SAS
PAR:NACON
|
FR |
|
Mitsubishi HC Capital Inc
TSE:8593
|
JP |
|
P
|
Polyus PJSC
LSE:PLZL
|
RU |
|
Elica SpA
MIL:ELC
|
IT |
|
Reservoir Media Inc
NASDAQ:RSVR
|
US |
|
V
|
VKTR Teknologi Mobilitas Tbk PT
IDX:VKTR
|
ID |
|
U
|
Unilever PLC
VSE:ULVR
|
UK |
|
AZZ Inc
NYSE:AZZ
|
US |
|
C
|
China Mobile Ltd
DUS:CTM
|
CN |
|
Camden Property Trust
NYSE:CPT
|
US |
|
Arverne Group SA
PAR:ARVEN
|
FR |
|
Mid-America Apartment Communities Inc
NYSE:MAA
|
US |
|
M
|
Murray & Roberts Holdings Ltd
SWB:LDYA
|
ZA |
|
Peach Property Group AG
SIX:PEAN
|
CH |
|
Bank of China Ltd
SSE:601988
|
CN |
Wall St Price Targets
SUPN Price Targets Summary
Supernus Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for SUPN is 64.09 USD with a low forecast of 55.55 USD and a high forecast of 69.3 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SUPN's stock price target?
Price Target
64.09
USD
According to Wall Street analysts, the average 1-year price target for SUPN is 64.09 USD with a low forecast of 55.55 USD and a high forecast of 69.3 USD.
What is the Revenue forecast for Supernus Pharmaceuticals Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 61%. The projected CAGR for the next 8 years is 8%.
What is the Operating Income forecast for Supernus Pharmaceuticals Inc?
Projected CAGR
62%
The compound annual growth rate for Operating Income over the next 8 years is 62%.
